Showing 221 - 240 results of 805 for search '"Demyelinating disease"', query time: 0.09s Refine Results
  1. 221

    Pregnancy and neuromyelitis optica by Qiu-ying MA, Jia-wei WANG

    Published 2016-10-01
    “…<p>Neuromyelitis optica (NMO) is an idiopathic inflammatory demyelinating disease, which mainly affects the optic nerve and spinal cord. …”
    Get full text
    Article
  2. 222

    Role of therapeutic plasma exchange in neuromyelitis optica: A case series by Rashmi Parashar, Amit Sharma, Ankit Sharma

    Published 2022-01-01
    “…Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the optic nerves and spinal cord and generally has a relapsing course. …”
    Get full text
    Article
  3. 223

    Rehabilitation treatment in multiple sclerosis by Katarzyna Ciechanowska, Alicja Roeske

    Published 2018-07-01
    “…Multiple sclerosis (Latin: sclerosis multiplex, SM) it is a chronic demyelinating disease, which requires a comprehensive and continuous physiotherapy By improving the complexity of therapy, the lifespan of patients with multiple sclerosis has been equal to the average life expectancy of a healthy individual. …”
    Get full text
    Article
  4. 224

    Neuromyelitis optica spectrum disorders in pediatric patients by Yu. V. Tokareva, A. S. Kotov, M. V. Panteleeva, M. S. Bunak

    Published 2018-04-01
    “…Neuromyelitis optica spectrum disorders (NMOSDs) is an inflammatory demyelinating disease of the central nervous system with a selective injury of the optic nerves and spinal cord. …”
    Get full text
    Article
  5. 225

    Practice current: how do you treat neuromyelitis optica? by Ganesh, A

    Published 2017
    “…It is estimated to affect about 1-3 individuals per 100,000 in the general world population, but is overrepresented in nonwhite populations (particularly Asians and those of Afro-Caribbean descent) as a major proportion of CNS demyelinating disease. 1-5 It follows a relapsing course in the majority of individuals, and most patients have early disability due to severe relapses; within 5 years of disease onset, over 50% of patients with relapsing NMO are blind in one eye or both eyes or require ambulatory support. 6,7…”
    Journal article
  6. 226

    Genetics of multiple sclerosis. by Ebers, G, Dyment, D

    Published 1998
    “…Multiple sclerosis (MS) is a common demyelinating disease of the central nervous system affecting primarily young adults. …”
    Journal article
  7. 227

    The emerging role of vitamin D binding protein in multiple sclerosis. by Disanto, G, Ramagopalan, S, Para, A, Handunnetthi, L

    Published 2011
    “…Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system (CNS). …”
    Journal article
  8. 228

    B cells in multiple sclerosis by Hartmut Wekerle

    Published 2017-01-01
    “…Multiple sclerosis is commonly considered as an autoimmune demyelinating disease, where myelin-reactive T cells enter the CNS from outside, and drive the inflammatory changes that ultimately create the degenerative MS plaque. …”
    Get full text
    Article
  9. 229

    Optical coherence tomography – a useful examination in the fight against multiple sclerosis by Anabella-Cristiana Cioabla, Cecilia Adumitresi, Ninela Radulescu, Ileana Ion

    Published 2018-12-01
    “…Multiple sclerosis is a demyelinating disease that affects the young adult and produces major disability. …”
    Get full text
    Article
  10. 230

    Progressive multifocal leukoencephalopathy selectively affecting Broca's and Wernicke's areas in an immunocompetent patient: A case report by Renaid B. Kim, BS, David N. Irani, MD, John Kim, MD

    Published 2023-03-01
    “…Progressive multifocal leukoencephalopathy (PML) is a rare, often fatal, demyelinating disease of the central nervous system. The disease almost exclusively presents in immunosuppressed patients, such as those with acquired immunodeficiency syndrome, a hematopoietic malignancy, or a transplanted organ; it is extremely rare in patients without immunosuppression. …”
    Get full text
    Article
  11. 231

    Comorbidity of Bipolar Disorder and Multiple Sclerosis: A Case Report by Necla Keskin, Soner Cakmak, Lut Tamam, Ahmet Turan Evlice

    Published 2013-08-01
    “…Multiple sclerosis is a chronic demyelinating disease of a central nervous system. Neuropsychiatric symptoms are common in multiple sclerosis and bipolar disorder is one of the most common psychiatric disorders that coexist with multiple sclerosis. …”
    Get full text
    Article
  12. 232

    Generation of Pelizaeus-Merzbacher disease (PMD) mutant (PLP1-C33Y) in induced pluripotent stem cell (iPSC) by CRISPR/Cas9 genome editing by Marie-Kristin Schreiber, Maria-Patapia Zafeiriou

    Published 2024-02-01
    “…Genetic alterations in the PLP1 gene, i.e. point mutations and duplications, are associated with demyelinating disease Pelizaeus-Merzbacher. Here, we describe the generation of a human iPSC line harboring a PLP1 variant in codon 33 which leads to an amino acid change from cysteine to tyrosine. …”
    Get full text
    Article
  13. 233

    MOG antibody associated disorder (MOGAD) by Lilley Kate, Sudarshini Ramanathan, Russell C Dale, Fabienne Brilot, Simon Broadley

    Published 2021-01-01
    “…The existence of antibodies to myelin oligodendrocyte glycoprotein (MOG) in some patients with CNS demyelinating disease has been recognised for 30 years, but their clinical utility as biomarkers, and potential pathogenicity in humans has only become apparent in the past 15 years. …”
    Get full text
    Article
  14. 234

    Recurrent tumefactive demyelinating lesions in an elderly woman by Erika L. Weil, MD, Mohammad Obadah Nakawah, MD

    Published 2022-12-01
    “…This case highlights several atypical features associated with tumefactive demyelinating disease, including an older age of onset and recurrent, treatment-resistant lesions. …”
    Get full text
    Article
  15. 235

    Update on immunopathogenesis and immunotherapy in multiple sclerosis by Selter RC, Hemmer B

    Published 2013-04-01
    “…Rebecca C Selter,1 Bernhard Hemmer1&ndash;3 1Department of Neurology, Klinikum Rechts der Isar, Technische Universit&auml;t M&uuml;nchen, Munich, Germany; 2Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; 3Competence Network on Multiple Sklerosis, Munich, Germany Abstract: Multiple sclerosis is a chronic inflammatory demyelinating disease of the central nervous system. Both genetic and environmental factors are believed to contribute to the pathogenesis of the disease. …”
    Get full text
    Article
  16. 236

    AIDS-related progressive multifocal leukoencephalopathy by Carolina de Oliveira Abrão, Lissa Rodrigues Machado da Silva, Luiz Carlos Silva Souza, Nathalia de Mello Bisso, Marília Dalva Turchi, Adriana Oliveira Guilarde

    Published 2020-12-01
    “…Abstract INTRODUCTION: Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system caused by reactivation of JC virus (JCV). …”
    Get full text
    Article
  17. 237

    Risk factors increasing the incidence of multiple sclerosis (MS) by Monika Kuc, Agnieszka Siedlak, Katarzyna Cyboran, Dominik Machaj, Alicja Płaczek

    Published 2022-08-01
    “… Multiple sclerosis is a chronic demyelinating disease. The etiology of MS is complex and can be associated with many different factors acting simultaneously or in a cascade. …”
    Get full text
    Article
  18. 238

    Newly Diagnosed Multiple Sclerosis Presenting as Brown-Séquard Syndrome: A Case Report by Shelby Hoebee, Levi Howard, James Komara, Megan McElhinny

    Published 2022-05-01
    “…Conclusion: This case highlights the need to have demyelinating disease on the differential as an exceedingly rare, but important, possible cause of Brown-Séquard syndrome.…”
    Get full text
    Article
  19. 239

    Leucoencefalopatía hipóxica tardía Delayed Hypoxic Leukoencephalopathy by Pablo Sartori, Rolando Giannaula, Gabriela Orzuza

    Published 2012-06-01
    “…<br>Delayed Hypoxic Leukoencephalopathy (DHL) is a rare demyelinating disease. This condition occurs days or weeks after a hypoxic-anoxic injury. …”
    Get full text
    Article
  20. 240

    Double Filtration Plasmapheresis in the Treatment of a Case with Acute Disseminated Encephalomyelitis by Mehmet Uğur Çevik, Mehmet Guli Çetinçakmak, Sefer Varol, Eşref Akıl

    Published 2013-06-01
    “…Acute disseminated encephalomyelitis (ADEM), is a monophasic autoimmune demyelinating disease of the central nervous system. Although high-dose steroid management has been considered the mainstay of treatment for ADEM, some patients are unresponsive to steroid therapy. …”
    Get full text
    Article